Soumaya Benjelloun
Overview
Explore the profile of Soumaya Benjelloun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hilmi S, Ouladlahsen A, Bencharki B, Haddaji A, Jebbar S, Bensghir R, et al.
AIDS Res Hum Retroviruses
. 2024 Dec;
41(2):69-75.
PMID: 39660359
The human immunodeficiency virus (HIV), a retrovirus targeting the immune system and the primary agent causing acquired immunodeficiency syndrome (AIDS), can have fatal consequences. Although antiretroviral treatment has significantly reduced...
2.
Aqillouch S, Zerrad C, Laazaazia O, Ouladlahsen A, El Bissati K, Akarid K, et al.
Hum Immunol
. 2024 Sep;
85(6):111149.
PMID: 39342923
Background: The clinical spectrum of COVID-19 varies considerably, ranging from asymptomatic cases to severe disease and even death. This variability can partly be attributed to genetic differences in genes associated...
3.
Zerrad C, Lkhider M, Bouqdayr M, Belkouchi A, Badre W, Tahiri M, et al.
Gene
. 2024 Aug;
931:148847.
PMID: 39147112
Background: Nucleotide-binding oligomerization domain 1 (NOD1) and NOD2 are involved in carcinogenic processes by recognizing bacterial cell wall components and triggering inflammation. This study explored the association between genetic variations...
4.
Tanouti I, Fellah H, Haddaji A, Zerrad C, Tahiri M, Badre W, et al.
Int J Immunogenet
. 2024 Apr;
51(4):206-216.
PMID: 38563185
Chronic inflammation triggered by hepatitis B (HBV) and hepatitis C (HCV) viruses elevates interleukin 6 (IL-6) levels, activating pathways that cause liver damage and contribute to hepatocellular carcinoma (HCC) development....
5.
Tanouti I, Fellah H, El Fihry R, Zerrad C, Abounouh K, Tahiri M, et al.
Asian Pac J Cancer Prev
. 2023 Nov;
24(11):3689-3696.
PMID: 38019226
Background: Hepatocellular carcinoma (HCC) is the most common primary malignancy. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) plays a crucial role in regulating the biogenesis of mitochondria. We aimed...
6.
Abounouh K, Tanouti I, Ouladlahsen A, Tahiri M, Badre W, Dehbi H, et al.
Infect Dis (Lond)
. 2023 Jun;
55(9):614-624.
PMID: 37376899
Background: Chronic hepatitis B virus (CHB) infection is still incurable a major public health problem. It is yet unclear how host genetic factors influence the development of HBV infection. The...
7.
Karami A, El Fihry R, Haddaji A, Jadid F, Zaidane I, Chihab H, et al.
Infect Dis (Lond)
. 2023 Jun;
55(9):625-634.
PMID: 37368360
Background: Hepatitis A virus (HAV) is the common cause of acute hepatitis worldwide. Indeed, hepatitis A is endemic in developing countries such in Morocco and most residents are exposed in...
8.
Zerrad C, Lkhider M, Belkouchi A, Tanouti I, Badre W, Tahiri M, et al.
Nucleosides Nucleotides Nucleic Acids
. 2023 Jun;
42(12):986-1003.
PMID: 37330637
Hepatocellular carcinoma (HCC) is the fifth most common human malignancy and the fourth most frequent cause of cancer-related deaths worldwide. Toll-like receptors (TLRs), are known to play a key role...
9.
Ezzemani W, Kettani A, Sappati S, Kondaka K, El Ossmani H, Tsukiyama-Kohara K, et al.
J Biomol Struct Dyn
. 2022 May;
41(11):4917-4938.
PMID: 35549819
The genome feature of SARS-CoV-2 leads the virus to mutate and creates new variants of concern. Tackling viral mutations is also an important challenge for the development of a new...
10.
Ezzemani W, Windisch M, Altawalah H, Guessous F, Saile R, Benjelloun S, et al.
J Biomol Struct Dyn
. 2022 Mar;
41(9):3762-3771.
PMID: 35318896
Zika virus (ZIKV), an RNA virus, rapidly spreads mosquito-borne sickness. Currently, there are neither effective vaccines nor therapeutics available to prevent or treat ZIKV infection. In this study, to address...